APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olanzapine

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Selected research

Market Structure

Global Olanzapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchOlanzapine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Olanzapine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Olanzapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olanzapine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Olanzapine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.

North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.

Read the full market overview

In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.

This report provides an overview of the global Olanzapine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Olanzapine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Olanzapine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Olanzapine market size, projected growth trends, production technologies, key applications, and end-use industries.

Olanzapine Segment by Company

Lilly

Teva Pharmaceutical

Dr. Reddy's Laboratories

Apotex Inc.

Mylan Pharmaceuticals

Par Pharmaceutical

Aurobindo Pharma

Torrent Pharmaceuticals

Jubilant Lifesciences

Sun Pharmaceutical

Sandoz

Hansoh Pharmaceutical

WATSON Pharmaceuticals(Changzhou)

Zhejiang Langhua Pharmaceuticals

Olanzapine Segment by Type

Patent

Generics

Olanzapine Segment by Application

Olanzapine Tablets

Others

Olanzapine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olanzapine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Olanzapine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olanzapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Olanzapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Olanzapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Olanzapine Industry Trends Table 2. Olanzapine Industry Drivers Table 3. Olanzapine Industry Opportunities and Challenges Table 4. Olanzapine Industry Restraints Table 5. Global Olanzapine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Olanzapine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Olanzapine Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Olanzapine Sales Market Share by Manufacturers Table 9. Global Olanzapine Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Olanzapine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Olanzapine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Olanzapine Manufacturers, Product Type & Application Table 13. Global Olanzapine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Olanzapine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Patent Table 17. Major Manufacturers of Generics Table 18. Global Olanzapine Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Olanzapine Sales by Type (2021-2026) & (Kg) Table 20. Global Olanzapine Sales by Type (2027-2032) & (Kg) Table 21. Global Olanzapine Sales Market Share by Type (2021-2026) Table 22. Global Olanzapine Sales Market Share by Type (2027-2032) Table 23. Global Olanzapine Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Olanzapine Revenue by Type (2021-2026) & (Kg) Table 25. Global Olanzapine Revenue by Type (2027-2032) & (Kg) Table 26. Global Olanzapine Revenue Market Share by Type (2021-2026) Table 27. Global Olanzapine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Olanzapine Tablets Table 29. Major Manufacturers of Others Table 30. Global Olanzapine Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 31. Global Olanzapine Sales by Application (2021-2026) & (Kg) Table 32. Global Olanzapine Sales by Application (2027-2032) & (Kg) Table 33. Global Olanzapine Sales Market Share by Application (2021-2026) Table 34. Global Olanzapine Sales Market Share by Application (2027-2032) Table 35. Global Olanzapine Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Olanzapine Revenue by Application (2021-2026) & (Kg) Table 37. Global Olanzapine Revenue by Application (2027-2032) & (Kg) Table 38. Global Olanzapine Revenue Market Share by Application (2021-2026) Table 39. Global Olanzapine Revenue Market Share by Application (2027-2032) Table 40. Global Olanzapine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 41. Global Olanzapine Sales by Region (2021-2026) & (Kg) Table 42. Global Olanzapine Sales Market Share by Region (2021-2026) Table 43. Global Olanzapine Sales Forecasted by Region (2027-2032) & (Kg) Table 44. Global Olanzapine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 46. North America Olanzapine Sales by Country (2021-2026) & (Kg) Table 47. North America Olanzapine Sales by Country (2027-2032) & (Kg) Table 48. Europe Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 49. Europe Olanzapine Sales by Country (2021-2026) & (Kg) Table 50. Europe Olanzapine Sales by Country (2027-2032) & (Kg) Table 51. Asia Pacific Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 52. Asia Pacific Olanzapine Sales by Country (2021-2026) & (Kg) Table 53. Asia Pacific Olanzapine Sales by Country (2027-2032) & (Kg) Table 54. South America, Middle East and Africa Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. South America, Middle East and Africa Olanzapine Sales by Country (2021-2026) & (Kg) Table 56. South America, Middle East and Africa Olanzapine Sales by Country (2027-2032) & (Kg) Table 57. Global Olanzapine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Olanzapine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Olanzapine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Olanzapine Revenue Market Share by Region (2021-2026) Table 61. Global Olanzapine Revenue Market Share by Region (2027-2032) Table 62. Lilly Company Information Table 63. Lilly Business Overview Table 64. Lilly Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Lilly Olanzapine Product Portfolio Table 66. Lilly Recent Development Table 67. Teva Pharmaceutical Company Information Table 68. Teva Pharmaceutical Business Overview Table 69. Teva Pharmaceutical Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Pharmaceutical Olanzapine Product Portfolio Table 71. Teva Pharmaceutical Recent Development Table 72. Dr. Reddy's Laboratories Company Information Table 73. Dr. Reddy's Laboratories Business Overview Table 74. Dr. Reddy's Laboratories Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Dr. Reddy's Laboratories Olanzapine Product Portfolio Table 76. Dr. Reddy's Laboratories Recent Development Table 77. Apotex Inc. Company Information Table 78. Apotex Inc. Business Overview Table 79. Apotex Inc. Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Apotex Inc. Olanzapine Product Portfolio Table 81. Apotex Inc. Recent Development Table 82. Mylan Pharmaceuticals Company Information Table 83. Mylan Pharmaceuticals Business Overview Table 84. Mylan Pharmaceuticals Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Pharmaceuticals Olanzapine Product Portfolio Table 86. Mylan Pharmaceuticals Recent Development Table 87. Par Pharmaceutical Company Information Table 88. Par Pharmaceutical Business Overview Table 89. Par Pharmaceutical Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Par Pharmaceutical Olanzapine Product Portfolio Table 91. Par Pharmaceutical Recent Development Table 92. Aurobindo Pharma Company Information Table 93. Aurobindo Pharma Business Overview Table 94. Aurobindo Pharma Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Aurobindo Pharma Olanzapine Product Portfolio Table 96. Aurobindo Pharma Recent Development Table 97. Torrent Pharmaceuticals Company Information Table 98. Torrent Pharmaceuticals Business Overview Table 99. Torrent Pharmaceuticals Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Torrent Pharmaceuticals Olanzapine Product Portfolio Table 101. Torrent Pharmaceuticals Recent Development Table 102. Jubilant Lifesciences Company Information Table 103. Jubilant Lifesciences Business Overview Table 104. Jubilant Lifesciences Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Jubilant Lifesciences Olanzapine Product Portfolio Table 106. Jubilant Lifesciences Recent Development Table 107. Sun Pharmaceutical Company Information Table 108. Sun Pharmaceutical Business Overview Table 109. Sun Pharmaceutical Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Sun Pharmaceutical Olanzapine Product Portfolio Table 111. Sun Pharmaceutical Recent Development Table 112. Sandoz Company Information Table 113. Sandoz Business Overview Table 114. Sandoz Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Sandoz Olanzapine Product Portfolio Table 116. Sandoz Recent Development Table 117. Hansoh Pharmaceutical Company Information Table 118. Hansoh Pharmaceutical Business Overview Table 119. Hansoh Pharmaceutical Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Hansoh Pharmaceutical Olanzapine Product Portfolio Table 121. Hansoh Pharmaceutical Recent Development Table 122. WATSON Pharmaceuticals(Changzhou) Company Information Table 123. WATSON Pharmaceuticals(Changzhou) Business Overview Table 124. WATSON Pharmaceuticals(Changzhou) Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio Table 126. WATSON Pharmaceuticals(Changzhou) Recent Development Table 127. Zhejiang Langhua Pharmaceuticals Company Information Table 128. Zhejiang Langhua Pharmaceuticals Business Overview Table 129. Zhejiang Langhua Pharmaceuticals Olanzapine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio Table 131. Zhejiang Langhua Pharmaceuticals Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Olanzapine Distributors List Table 135. Olanzapine Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Olanzapine Product Image Figure 2. Global Olanzapine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olanzapine Market Size (2021-2032) & (US$ Million) Figure 4. Global Olanzapine Sales (2021-2032) & (Kg) Figure 5. Global Olanzapine Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Olanzapine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Patent Image Figure 9. Generics Image Figure 10. Global Olanzapine Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Olanzapine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Olanzapine Sales Market Share by Type (2021-2032) Figure 13. Global Olanzapine Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Olanzapine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Olanzapine Revenue Market Share by Type (2021-2032) Figure 16. Olanzapine Tablets Image Figure 17. Others Image Figure 18. Global Olanzapine Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 19. Global Olanzapine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Olanzapine Sales Market Share by Application (2021-2032) Figure 21. Global Olanzapine Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Olanzapine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Olanzapine Revenue Market Share by Application (2021-2032) Figure 24. North America Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 25. North America Olanzapine Sales Market Share by Country (2021-2032) Figure 26. U.S. Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 27. Canada Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Mexico Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Europe Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Olanzapine Sales Market Share by Country (2021-2032) Figure 31. Germany Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 32. France Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 33. U.K. Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Italy Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Netherlands Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Asia Pacific Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Olanzapine Sales Market Share by Country (2021-2032) Figure 38. China Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Japan Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 40. South Korea Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Southeast Asia Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 42. India Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Australia Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South America, Middle East and Africa Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Olanzapine Sales Market Share by Country (2021-2032) Figure 46. Brazil Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South Africa Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 48. Saudi Arabia Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Turkey Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Argentina Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 51. UAE Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Egypt Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Chile Olanzapine Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Global Olanzapine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Olanzapine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Olanzapine Revenue (2021-2032) & (US$ Million) Figure 57. North America Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Olanzapine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Olanzapine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Olanzapine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Olanzapine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Olanzapine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generics
Applications
  • Olanzapine Tablets
  • Others
Companies covered
  • Lilly
  • Teva Pharmaceutical
  • Dr. Reddy's Laboratories
  • Apotex Inc.
  • Mylan Pharmaceuticals
  • Par Pharmaceutical
  • Aurobindo Pharma
  • Torrent Pharmaceuticals
  • Jubilant Lifesciences
  • Sun Pharmaceutical
  • Sandoz
  • Hansoh Pharmaceutical
  • WATSON Pharmaceuticals(Changzhou)
  • Zhejiang Langhua Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Olanzapine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Olanzapine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Olanzapine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Olanzapine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Olanzapine Market Dynamics
  1. 2.1 Olanzapine Industry Trends
  2. 2.2 Olanzapine Industry Drivers
  3. 2.3 Olanzapine Industry Opportunities and Challenges
  4. 2.4 Olanzapine Industry Restraints
3 Olanzapine Market by Manufacturers
  1. 3.1 Global Olanzapine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Olanzapine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Olanzapine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Olanzapine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olanzapine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Olanzapine Manufacturers, Product Type & Application
  7. 3.7 Global Olanzapine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olanzapine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olanzapine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olanzapine Tier 1, Tier 2, and Tier 3
4 Olanzapine Market by Type
  1. 4.1 Olanzapine Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generics
  4. 4.2 Global Olanzapine Sales by Type
  5. 4.2.1 Global Olanzapine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Olanzapine Sales by Type (2021-2032)
  7. 4.2.3 Global Olanzapine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Olanzapine Revenue by Type
  9. 4.3.1 Global Olanzapine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Olanzapine Revenue by Type (2021-2032)
  11. 4.3.3 Global Olanzapine Revenue Market Share by Type (2021-2032)
5 Olanzapine Market by Application
  1. 5.1 Olanzapine Application Introduction
  2. 5.1.1 Olanzapine Tablets
  3. 5.1.2 Others
  4. 5.2 Global Olanzapine Sales by Application
  5. 5.2.1 Global Olanzapine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Olanzapine Sales by Application (2021-2032)
  7. 5.2.3 Global Olanzapine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Olanzapine Revenue by Application
  9. 5.3.1 Global Olanzapine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Olanzapine Revenue by Application (2021-2032)
  11. 5.3.3 Global Olanzapine Revenue Market Share by Application (2021-2032)
6 Global Olanzapine Sales by Region
  1. 6.1 Global Olanzapine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Olanzapine Sales by Region (2021-2032)
  3. 6.2.1 Global Olanzapine Sales by Region (2021-2026)
  4. 6.2.2 Global Olanzapine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Olanzapine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Olanzapine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Olanzapine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Olanzapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Olanzapine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Olanzapine Revenue by Region
  1. 7.1 Global Olanzapine Revenue by Region
  2. 7.1.1 Global Olanzapine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Olanzapine Revenue by Region (2021-2026)
  4. 7.1.3 Global Olanzapine Revenue by Region (2027-2032)
  5. 7.1.4 Global Olanzapine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Olanzapine Revenue (2021-2032)
  8. 7.2.2 North America Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Olanzapine Revenue (2021-2032)
  11. 7.3.2 Europe Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Olanzapine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Olanzapine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Olanzapine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lilly
  2. 8.1.1 Lilly Company Information
  3. 8.1.2 Lilly Business Overview
  4. 8.1.3 Lilly Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lilly Olanzapine Product Portfolio
  6. 8.1.5 Lilly Recent Developments
  7. 8.2 Teva Pharmaceutical
  8. 8.2.1 Teva Pharmaceutical Company Information
  9. 8.2.2 Teva Pharmaceutical Business Overview
  10. 8.2.3 Teva Pharmaceutical Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Olanzapine Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Recent Developments
  13. 8.3 Dr. Reddy's Laboratories
  14. 8.3.1 Dr. Reddy's Laboratories Company Information
  15. 8.3.2 Dr. Reddy's Laboratories Business Overview
  16. 8.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy's Laboratories Olanzapine Product Portfolio
  18. 8.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 8.4 Apotex Inc.
  20. 8.4.1 Apotex Inc. Company Information
  21. 8.4.2 Apotex Inc. Business Overview
  22. 8.4.3 Apotex Inc. Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apotex Inc. Olanzapine Product Portfolio
  24. 8.4.5 Apotex Inc. Recent Developments
  25. 8.5 Mylan Pharmaceuticals
  26. 8.5.1 Mylan Pharmaceuticals Company Information
  27. 8.5.2 Mylan Pharmaceuticals Business Overview
  28. 8.5.3 Mylan Pharmaceuticals Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Pharmaceuticals Olanzapine Product Portfolio
  30. 8.5.5 Mylan Pharmaceuticals Recent Developments
  31. 8.6 Par Pharmaceutical
  32. 8.6.1 Par Pharmaceutical Company Information
  33. 8.6.2 Par Pharmaceutical Business Overview
  34. 8.6.3 Par Pharmaceutical Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Par Pharmaceutical Olanzapine Product Portfolio
  36. 8.6.5 Par Pharmaceutical Recent Developments
  37. 8.7 Aurobindo Pharma
  38. 8.7.1 Aurobindo Pharma Company Information
  39. 8.7.2 Aurobindo Pharma Business Overview
  40. 8.7.3 Aurobindo Pharma Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aurobindo Pharma Olanzapine Product Portfolio
  42. 8.7.5 Aurobindo Pharma Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Olanzapine Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Jubilant Lifesciences
  50. 8.9.1 Jubilant Lifesciences Company Information
  51. 8.9.2 Jubilant Lifesciences Business Overview
  52. 8.9.3 Jubilant Lifesciences Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jubilant Lifesciences Olanzapine Product Portfolio
  54. 8.9.5 Jubilant Lifesciences Recent Developments
  55. 8.10 Sun Pharmaceutical
  56. 8.10.1 Sun Pharmaceutical Company Information
  57. 8.10.2 Sun Pharmaceutical Business Overview
  58. 8.10.3 Sun Pharmaceutical Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharmaceutical Olanzapine Product Portfolio
  60. 8.10.5 Sun Pharmaceutical Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Olanzapine Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Hansoh Pharmaceutical
  68. 8.12.1 Hansoh Pharmaceutical Company Information
  69. 8.12.2 Hansoh Pharmaceutical Business Overview
  70. 8.12.3 Hansoh Pharmaceutical Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hansoh Pharmaceutical Olanzapine Product Portfolio
  72. 8.12.5 Hansoh Pharmaceutical Recent Developments
  73. 8.13 WATSON Pharmaceuticals(Changzhou)
  74. 8.13.1 WATSON Pharmaceuticals(Changzhou) Company Information
  75. 8.13.2 WATSON Pharmaceuticals(Changzhou) Business Overview
  76. 8.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio
  78. 8.13.5 WATSON Pharmaceuticals(Changzhou) Recent Developments
  79. 8.14 Zhejiang Langhua Pharmaceuticals
  80. 8.14.1 Zhejiang Langhua Pharmaceuticals Company Information
  81. 8.14.2 Zhejiang Langhua Pharmaceuticals Business Overview
  82. 8.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio
  84. 8.14.5 Zhejiang Langhua Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Olanzapine Value Chain Analysis
  2. 9.1.1 Olanzapine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Olanzapine Production Mode & Process
  6. 9.2 Olanzapine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Olanzapine Distributors
  9. 9.2.3 Olanzapine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst